No Picture
Trading Ideas

Senate Democrats Ramp Up Scrutiny of Trump’s Fannie-Freddie Plan

(Bloomberg) — It’s been three months since the Trump administration released its plan to end government control of Fannie Mae and Freddie Mac and Democratic lawmakers still have unanswered questions, lots of them.In a Tuesday letter, Senate Banking Committee Democrats put almost two dozen queries to the Treasury Department and Federal Housing Finance Agency, the companies’ regulator. Topics ranged from the potential impact releasing Fannie and Freddie will have on the trillions of dollars in mortgage securities that the companies backstop to whether housing costs will rise.Virginia Senator Mark Warner, Presidential candidate Elizabeth Warren and other Democrats who signed the …read more […]

No Picture
Trading Ideas

Is Netflix’s 'The Irishman' actually a flop?

Netflix announced that ‘The Irishman’ garnered streams from 26.4 million households globally in its first week, falling nearly 50% lower than the numbers posted by the streaming giant’s ‘Bird Box’. Yahoo Finance’s Zack Guzman, Kristin Myers and The Brewer Group CEO & Former NFL Player Jack Brewer discuss on YFi PM. …read more […]

No Picture
Trading Ideas

The Best Stocks From the Last 10 Years

We’re approaching the end of the year.
It’s a time for all of us to look back and reflect.
And as we cross into a new decade – waving goodbye to the 2010s – we’re also stepping into history.
We’re witnessing an event rarer than the appearance of Halley’s Comet. Rarer than watching Venus’ transit across the surface of the sun.
In fact, it’s something that hasn’t happened in 170 years.
For the first time since before the Civil War, the U.S. hasn’t fallen into a recession during a 10-year period.
That may not seem momentous. But like clockwork, in every decade for the past 170 …read more […]

Healthcare

CytoDyn (OTC: CYDY) Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

VANCOUVER, Washington and NEW YORK, Dec 17, 2019 – In exchange for the exclusive right to market and distribute leronlimab in the U.S. for HIV-related indications, Vyera will pay upfront and regulatory and sales-based milestone […]